Cargando…
Pan-cancer genomic analysis shows hemizygous PTEN loss tumors are associated with immune evasion and poor outcome
In tumors, somatic mutations of the PTEN suppressor gene are associated with advanced disease, chemotherapy resistance, and poor survival. PTEN loss of function may occur by inactivating mutation, by deletion, either affecting one copy (hemizygous loss) leading to reduced gene expression or loss of...
Autores principales: | Vidotto, T., Melo, C. M., Lautert-Dutra, W., Chaves, L. P., Reis, R. B., Squire, J. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10050165/ https://www.ncbi.nlm.nih.gov/pubmed/36977733 http://dx.doi.org/10.1038/s41598-023-31759-6 |
Ejemplares similares
-
Emerging role of PTEN loss in evasion of the immune response to tumours
por: Vidotto, Thiago, et al.
Publicado: (2020) -
The Role of Somatic Mutations on the Immune Response of the Tumor Microenvironment in Prostate Cancer
por: Melo, Camila Morais, et al.
Publicado: (2021) -
Distinct subtypes of genomic PTEN deletion size influence the landscape of aneuploidy and outcome in prostate cancer
por: Vidotto, Thiago, et al.
Publicado: (2018) -
FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome
por: Yoshimoto, M, et al.
Publicado: (2007) -
Identification of tumor-agnostic biomarkers for predicting prostate cancer progression and biochemical recurrence
por: Lautert-Dutra, William, et al.
Publicado: (2023)